NeoGenomics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
NeoGenomics, Inc. (NEO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -6.73% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-17
- NeoGenomics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -6.73%.
- NeoGenomics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -6.51%.
- NeoGenomics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -4.13%.
- NeoGenomics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -2.17%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -6.73% 10-K · filed 2026-02-17 | |
| 2024-12-31 | -6.51% 10-K · filed 2026-02-17 | -6.49% 10-K · filed 2025-02-18 |
| 2023-12-31 | -4.13% 10-K · filed 2026-02-17 | |
| 2022-12-31 | -2.17% 10-K · filed 2025-02-18 | |
| 2021-12-31 | -0.96% 10-K · filed 2024-02-20 | |
| 2020-12-31 | 65.78% 10-K · filed 2023-02-24 | |
| 2019-12-31 | -135.12% 10-K · filed 2022-02-25 | |
| 2018-12-31 | -12.52% 10-K · filed 2021-02-25 | |
| 2017-12-31 | -25.95% 10-K · filed 2020-02-28 | -19.76% 10-K · filed 2018-03-13 |
| 2016-12-31 | -13.37% 10-K · filed 2019-02-26 | |
| 2015-12-31 | -10.24% 10-K · filed 2018-03-13 | |
| 2014-12-31 | 4.00% 10-K · filed 2017-03-14 | |
| 2013-12-31 | 14.45% 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |